1. Lymphomatoid Granulomatosis in HIV-2: A Rare Entity
- Author
-
Ana Gonçalves, T. J. F. Branco, Susana G. Pereira, Clara Matos, and Sofia Carola
- Subjects
medicine.medical_specialty ,Lymphomatoid granulomatosis ,business.industry ,General Engineering ,Human immunodeficiency virus (HIV) ,Rare entity ,Hematology ,medicine.disease ,medicine.disease_cause ,chemotherapy ,Dermatology ,lymphomatoid granulomatosis ,human immunodeficiency virus type 2 ,Oncology ,hemic and lymphatic diseases ,Medicine ,HIV/AIDS ,business ,lymphoproliferative disorder ,epstein-bar virus - Abstract
Lymphomatoid granulomatosis (LYG) is a rare B-cell lymphoproliferative disorder associated with Epstein-Barr virus (EBV) infection and is frequently associated with immunodeficiency. Pulmonary involvement with angiocentric distribution is the most common clinical manifestation. Diagnosis is confirmed by tissue biopsy, usually from lung lesions. Due to the paucity of reported cases, there is no validated treatment for LYG. Therapeutic options include interferon-alpha, systemic corticosteroids, rituximab, chemotherapy, and autologous hematopoietic stem cell transplantation. We report a case of a 49-year-old man, with human immunodeficiency virus type 2 (HIV-2) infection, who was diagnosed with LYG with lung involvement and had a full remission after treatment with R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone).
- Published
- 2021